Columnist Dagmar Munn says she has often felt out of place in the ALS community because of the slower pace of her disease progression.
ALS, which is also known as Lou Gehrig's Disease, is a rare neurological disease that affects motor neurons — the nerve cells ...
Among participants who met the core RESTORE-ALS Trial criteria (e.g., baseline serum NfL > 33 pg/mL, TRICALS risk score range between –6.5 and –2.5, baseline slow vital capacity > 60%, and symptom ...
News Medical on MSN6d
St. Jude researchers improve brain disease diagnosis with PET imaging and ALS drugPositron emission tomography (PET) is a nuclear imaging technique used to diagnose conditions such as cancer. An innovative advance from scientists at St. Jude Children's Research Hospital is ...
IEEE Spectrum on MSN9h
New Brain Tech Gives Voice to ALS PatientsA myotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that affects muscle control, and most ...
Pathmaker's MyoRegulator is designed to ease hyperexcitability and delivers an electrical current to the spinal cord and ...
Scientists used positron emission tomography (PET) with edaravone, a drug used to treat ALS, to detect oxidative stress, which leads to brain damage, offering a clear path to detecting neurological ...
A new study compares three types of blood biomarkers: neurofilament light chain proteins, glial acidic proteins and phosphorylated tau 181.
ALS impacts tens of thousands of people across the United States, and hundreds in Arizona. There's research being done in the Valley that can hopefully help contribute to ending ALS.
Neurodegenerative diseases, such as ALS and Alzheimer's disease, are largely diagnosed by physical symptoms that occur when treatment is often too late to be effective. Reactive oxygen and ...
A Regina mother who was one of the first ALS patients to test a new treatment is now celebrating its accelerated approval in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback